Skip to Main Content
Sidney Kimmel Cancer Center
Together
Until Every Cancer is Cured

Register

Event registration icon

Used for reminders. No spam guarantee.

Events iconEvents

Research

Sidney Kimmel Cancer Center Grand Rounds Lecture

Nov 20th 12:00 PM

/content/skcc/events/sidney-kimmel-cancer-center-grand-rounds-lecture12

"New Agents in Drug Development" — Johanna Bendell, MD, Chief Development Officer; Director, GI Cancer Research Program, Sarah Cannon, Nashville, Tenn.

/content/dam/skcc/events/SKCC_Kiosk_EventAd_GenericDefault.png

2019-11-20T12:00:00-0500

2019-11-20T13:00:00-0500

Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Location: Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Description: "New Agents in Drug Development" — Johanna Bendell, MD, Chief Development Officer; Director, GI Cancer Research Program, Sarah Cannon, Nashville, Tenn.

Registration is not required for this event.

Research

Joint Research Seminar

Nov 25th 12:00 PM

/content/skcc/events/joint-research-seminar10

Hosted by the Department of Biochemistry & Molecular Biology and the Department of Cancer Biology at SKCC.

Karen Maxwell, PhD, Associate Professor of Biochemistry, University of Toronto

/content/dam/skcc/events/SKCC_Kiosk_EventAd_GenericDefault.png

2019-11-25T12:00:00-0500

2019-11-25T13:00:00-0500

Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Location: Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Description: Karen Maxwell, PhD, Associate Professor of Biochemistry, University of Toronto

Registration is not required for this event.

Research

Joint Research Seminar

Dec 2nd 12:00 PM

/content/skcc/events/joint-research-seminar11

Hosted by the Department of Biochemistry & Molecular Biology and the Department of Cancer Biology at SKCC.

David W. Goodrich, PhD, Professor of Oncology, Department of Pharmacology & Therapeutics; Associate Dean for Postdoctoral Education, Roswell Park Comprehensive Cancer Center, Buffalo, N.Y.

/content/dam/skcc/events/SKCC_Kiosk_EventAd_GenericDefault.png

2019-12-02T12:00:00-0500

2019-12-02T13:00:00-0500

Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Location: Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Description: David W. Goodrich, PhD, Professor of Oncology, Department of Pharmacology & Therapeutics; Associate Dean for Postdoctoral Education, Roswell Park Comprehensive Cancer Center, Buffalo, N.Y.

Registration is not required for this event.

Research

Joint Research Seminar

Dec 9th 12:00 PM

/content/skcc/events/joint-research-seminar12

Hosted by the Department of Biochemistry & Molecular Biology and the Department of Cancer Biology at SKCC.

Christopher Schultz, Genetics, Genomics & Cancer Biology Doctoral Candidate; and Azadeh Sarfalleh, Molecular Biology & Pharmacology Doctoral Candidate, Thomas Jefferson University

/content/dam/skcc/events/SKCC_Kiosk_EventAd_GenericDefault.png

2019-12-09T12:00:00-0500

2019-12-09T13:00:00-0500

Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Location: Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Description: Christopher Schultz, Genetics, Genomics & Cancer Biology Doctoral Candidate; and Azadeh Sarfalleh, Molecular Biology & Pharmacology Doctoral Candidate, Thomas Jefferson University

Registration is not required for this event.

Research

Joint Research Seminar

Dec 16th 12:00 PM

/content/skcc/events/joint-research-seminar13

Hosted by the Department of Biochemistry & Molecular Biology and the Department of Cancer Biology at SKCC.

Karen Usdin, PhD, Senior Investigator, Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health

/content/dam/skcc/events/SKCC_Kiosk_EventAd_GenericDefault.png

2019-12-16T12:00:00-0500

2019-12-16T13:00:00-0500

Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Location: Bluemle Life Sciences Building, Mandeville Auditorium (Room 101), 233 S. 10th Street

Description: Karen Usdin, PhD, Senior Investigator, Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health

Registration is not required for this event.

Programs

Programs

Accelerating discovery in five NCI-designated Research Program areas, aiming to translate findings into more effective treatments.


Shared Resources

Shared Resources

Six NCI-funded Shared Resources provide collective access to equipment, data and support, benefitting scientists whose research findings help improve patients' lives. 


Clinical Trials

Clinical Trials

Exploring new ways to prevent, diagnose and treat cancer.


Patients who participate in our advanced clinical trials are often
the first to benefit from promising new cancer treatments. 

Types

Screening Trials study better ways to test for and detect cancer.

Prevention Trials test methods for reducing the risk of cancer in people who’ve never had it or for preventing it from recurring in patients who have.

Diagnostic Trials study procedures or tests for diagnosing specific types of cancers.Trials study procedures or tests for diagnosing specific types of cancers.

Therapeutic Trials look for new medicines, therapies and methods for treating cancer.

Quality of Life Trials explore ways to improve comfort and quality of life for cancer patients.

Phases

Phase I Trials evaluate how a new drug should be given, e.g. orally or intravenously; usually on a small number of patients.

Phase II Trials test drug safety and how well the new drug works, usually focusing on a particular type of cancer.

Phase III Trials test new drugs or surgical procedures in comparison to the current standard often including a large number of patients who are assigned to either the standard or new group.

Phase IV Trials evaluate side effects, risks and benefits of a drug over a longer period of time; usually a larger number of people than in Phase III. 

Benefits

In addition to gaining access to new treatments that are not yet available to the general public, you help fellow patients and future generations by contributing to medical research. You may have access to innovative medicines, treatments or supportive therapies at low or no cost, too. And although clinical trials offer no guarantees, physicians believe that the study drug or cancer treatment will provide benefits equal to or better than the current standard therapies.

Back
Clinical trials icon
< Back to trials listing

Is a clinical trial right for you?

Ultimately, only you and your Cancer Care 360 team can determine if a clinical trial is appropriate. Our team will walk you through the key considerations and criteria for open trials, such as your age, the type and stage of cancer you have, any previous treatments you have undergone, and other medical conditions. 

 

For general information on Clinical Trials, contact the
Sidney Kimmel Cancer Center Clinical Research Organization at 215-955-1661.


Grants

Grants

Securing funding for research is a crucial step in the quest for a cure.
The Sidney Kimmel Cancer Center and research support teams at Jefferson Health are here to help manage the process.

Sidney Kimmel
Cancer Center
Map marker
Shuttle bus icon
Track From Anywhere Shuttle.Jefferson.edu
Schedule an appointment
Make a donation